Cargando…
Novel Self-Forming Nanosized DDS Particles for BNCT: Utilizing A Hydrophobic Boron Cluster and Its Molecular Glue Effect
BNCT is a non-invasive cancer therapy that allows for cancer cell death without harming adjacent cells. However, the application is limited, owing to the challenges of working with clinically approved boron (B) compounds and drug delivery systems (DDS). To address the issues, we developed self-formi...
Autores principales: | Fithroni, Abdul Basith, Kobayashi, Kazuko, Uji, Hirotaka, Ishimoto, Manabu, Akehi, Masaru, Ohtsuki, Takashi, Matsuura, Eiji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600043/ https://www.ncbi.nlm.nih.gov/pubmed/36291173 http://dx.doi.org/10.3390/cells11203307 |
Ejemplares similares
-
A Novel (89)Zr-labeled DDS Device Utilizing Human IgG Variant (scFv): “Lactosome” Nanoparticle-Based Theranostics for PET Imaging and Targeted Therapy
por: Lim, Melissa Siaw Han, et al.
Publicado: (2021) -
Aptamers for Addressed Boron Delivery in BNCT: Effect of Boron Cluster Attachment Site on Functional Activity
por: Novopashina, Darya S., et al.
Publicado: (2022) -
Quantification of Boron Compound Concentration for BNCT Using Positron Emission Tomography
por: Balcerzyk, Marcin, et al.
Publicado: (2020) -
Evaluation of a Novel Boron-Containing α-d-Mannopyranoside for BNCT
por: Tsurubuchi, Takao, et al.
Publicado: (2020) -
Recent Advances in the Synthesis of High Boron-Loaded Nucleic Acids for BNCT
por: Novopashina, Darya Sergeevna, et al.
Publicado: (2021)